Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Puma Biotechnology, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 121 | 132 | +11 |
| Shares | 32.8M | 34.4M | +1.57M (+4.8%) |
| Value | $112.5M | $182.5M | +$70.0M (+62.2%) |
New holders (23)
Institutions that held Puma Biotechnology, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (12)
Institutions that held Puma Biotechnology, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Janus Henderson Group PLC | 745,541 | $2.56M |
| Citadel Advisors LLC | 507,818 | $1.74M |
| Eversept Partners, LP | 240,688 | $825.6K |
| State Board of Administration of Florida Retirement System | 71,727 | $246.0K |
| Kapitalo Investimentos Ltda | 70,269 | $241.0K |
| Susquehanna International Group, LLP | 57,724 | $198.0K |
| HSBC Holdings PLC | 19,751 | $66.6K |
| Ieq Capital, LLC | 14,305 | $49.1K |
| Voya Investment Management LLC | 12,976 | $44.5K |
| Williams & Novak, LLC | 12,520 | $42.9K |
| Fourth Dimension Wealth, LLC | 500 | $1.72K |
| South State Corp. | 111 | $381 |